Sundhedsvidenskabelig Forskning ved Aarhus - Institutleder til ...

MEDICINSK-ENDOKRINOLOGISK AFDELING C, ÅRHUS UNIVERSITETSHOSPITAL,
ÅRHUS SYGEHUS,
vol. 84, nr. 4, s. 276-85.
Positano, V, Christiansen, T, Santarelli, MF, Ringgaard,
S, Landini, L & Gastaldelli, A 2009, ‘Accurate
segmentation of subcutaneous and intermuscular
adipose tissue from MR images of the thigh’,
Journal of Magnetic Resonance Imaging, vol. 29, nr.
3, s. 677-84.
Recker, RR, Ste-Marie, L, Langdahl, B, Masanauskaite,
D, Ethgen, D & Delmas, PD 2009, ‘Oral ibandronate
preserves trabecular microarchitecture: microcomputed
tomography findings from the oral
iBandronate Osteoporosis vertebral fracture trial
in North America and Europe study’, Journal of
Clinical Densitometry, vol. 12, nr. 1, s. 71-6.
Rejnmark, L, Langdahl, BL & Mosekilde, L 2009, ‘Osteoporose
udredning og behandling’, Maanedsskrift
for Praktisk Laegegerning, vol. 87, s. 241-253.
Rejnmark, L, Tietze, A, Vestergaard, P, Buhl, L, Lehbrink,
M, Heickendorff, L & Mosekilde, L 2009,
‘Reduced Prediagnostic 25-Hydroxyvitamin D
Levels in Women with Breast Cancer: A Nested
Case-Control Study’, Cancer Epidemiology, Biomarkers
& Prevention, s. 2655-2660.
Rejnmark, L, Vestergaard, P, Heickendorff, L & Mosekilde,
L 2009, ‘Simvastatin does not affect vitamin
d status, but low vitamin d levels are associated
with dyslipidemia: results from a randomised, controlled
trial’, International journal of endocrinology.
Richelsen, B 2009, ‘Fysisk aktivitet er sundt--kosttilskud
og doping er ikke’, Ugeskrift for læger, vol. 171,
nr. 34, s. 2370.
Richelsen, B 2009, ‘Har medicinsk behandling af fedme
en fremtid?’, Ugeskrift for læger, vol. 171, nr. 41, s.
2973.
Richelsen, B & Pedersen, SB 2009, ‘Raske overvaegtige.
Er vaegttabsbehandling indiceret?’, Ugeskrift
for læger, vol. 171, nr. 43, s. 3092-4.
Rubeck, KZ, Bertelsen, S, Vestergaard, P & Jørgensen,
JOL 2009, ‘Impact of growth hormone (GH) substitution
on exercise capacity and muscle strength
in GH-deficient adults: a meta-analysis of blinded,
placebo-controlled trials’, Clinical Endocrinology,
vol. 71, nr. 6, s. 860-6.
Ryg, J, Rejnmark, L, Overgaard, S, Brixen, K & Vestergaard,
P 2009, ‘Hip fracture patients at risk of second
hip fracture: a nationwide population-based
cohort study of 169,145 cases during 1977-2001’,
Journal of Bone and Mineral Research, vol. 24, nr. 7,
s. 1299-307.
Sanden, AK & Vestergaard, P 2009, ‘Kontrol af serumcalcium
med cinacalcet ved parathyroideacancer’,
Ugeskrift for læger, vol. 171, nr. 41, s. 3004-6.
Silverberg, SJ, Lewiecki, EM, Mosekilde, L, Peacock, M
& Rubin, MR 2009, ‘Presentation of asymptomatic
primary hyperparathyroidism: proceedings of the
third international workshop’, Journal of Clinical
Endocrinology and Metabolism, vol. 94, nr. 2, s.
351-65.
Svendsen, P, Madsbad, S, Nilas, L, Paulsen, SK & Pedersen,
SB 2009, ‘Expression of 11beta-hydroxysteroid
dehydrogenase 1 and 2 in subcutaneous adipose
tissue of lean and obese women with and without
polycystic ovary syndrome.’, International Journal
of Obesity, vol. 11, s. 1249-56.
Vestergaard, P 2009, ‘Bone metabolism in type 2 diabetes
and role of thiazolidinediones’, Current opinion
in endocrinology, diabetes, and obesity, vol. 16, nr.
2, s. 125-31.
Vestergaard, P, Rejnmark, L & Mosekilde, L 2009, ‘Diabetes
and its complications and their relationship
with risk of fractures in type 1 and 2 diabetes’, Calcified
Tissue International, vol. 84, nr. 1, s. 45-55.
Vestergaard, P, Rejnmark, L & Mosekilde, L 2009, ‘Fracture
risk in patients with different types of cancer’,
Acta Odontologica Scandinavica, vol. 48, nr. 1, s.
105-15.
Vestergaard, P 2009, ‘Fracture risks of antidepressants’,
Expert Review of Neurotherapeutics, vol. 9,
nr. 1, s. 137-41.
Vestergaard, P, Schwartz, K, Pinholt, E, Rejnmark, L &
Mosekilde, L 2009, ‘Gastric and Esophagus Events
Before and During Treatment of Osteoporosis’,
Calcified Tissue International, s. 110-5.
Vestergaard, P, Rejnmark, L & Mosekilde, L 2009, ‘Hypertension
is a risk factor for fractures’, Calcified
Tissue International, vol. 84, nr. 2, s. 103-11.
Vestergaard, P, Rejnmark, L & Mosekilde, L 2009, ‘Loss
of life years after a hip fracture’, Acta Orthopaedica
(Print Edition), vol. 80, nr. 5, s. 525-30.
Vestergaard, P & Mosekilde, L 2009, ‘Medicinsk
behandling af patienter med primær hyperparathyroidisme’,
Ugeskrift for læger, vol. 171, nr. 33,
s. 2284-7.
Vestergaard, P, Rejnmark, L & Mosekilde, L 2009, ‘Osteoarthritis
and risk of fractures’, Calcified Tissue
International, vol. 84, nr. 4, s. 249-56.
Vestergaard, P 2009, ‘Varying effects of psychotropic
medications on fracture risk in older people’, Evidence
- Based Mental Health, vol. 12, nr. 1, s. 25.
Review
Sundhedsvidenskabelig Forskning ved Aarhus Universitet og Århus Universitetshospital 2009 163